Pictet Asset Management (UK)’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $37.9M | Buy |
557,480
+140,600
| +34% | +$9.56M | 0.04% | 398 |
|
|
2021
Q1 | $32.1M | Sell |
416,880
-55,097
| -12% | -$4.24M | 0.04% | 415 |
|
|
2020
Q4 | $28.3M | Sell |
471,977
-7,479
| -2% | -$449K | 0.04% | 417 |
|
|
2020
Q3 | $20.6M | Buy |
479,456
+272,864
| +132% | +$11.7M | 0.03% | 424 |
|
|
2020
Q2 | $8.56M | Buy |
206,592
+58,995
| +40% | +$2.44M | 0.01% | 555 |
|
|
2020
Q1 | $6.38M | Sell |
147,597
-63,582
| -30% | -$2.75M | 0.01% | 573 |
|
|
2019
Q4 | $11.7M | Sell |
211,179
-11,478
| -5% | -$636K | 0.02% | 530 |
|
|
2019
Q3 | $7.73M | Buy |
+222,657
| New | +$7.73M | 0.02% | 574 |
|